Listen "Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma"
Episode Synopsis
This article "Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma" is published in Immunity.Author: Kevin BiJournal: ImmunityYear: 2025Podcast type: ShortAuthors are:⦁ Kevin Bi⦁ Soki Kashima⦁ Sabrina Y. Camp⦁ Kevin Meli⦁ Eddy Saad⦁ Breanna M. Titchen⦁ Chris Labaki⦁ Ziad Bakouny⦁ Erica M. Pimenta⦁ Jihye Park⦁ Erin Shannon⦁ Jingxin Fu⦁ Sherin Xirenayi⦁ Jack Horst⦁ Lotus Lum⦁ Jeffrey J. Ishizuka⦁ Toni K. Choueiri⦁ David A. Braun⦁ Eliezer M. Van AllenAffiliations:Kevin Bi, Sabrina Y. Camp, Kevin Meli, Eddy Saad, Breanna M. Titchen, Chris Labaki, Erica M. Pimenta, Jihye Park, Erin Shannon, Jingxin Fu, Sherin Xirenayi, Eliezer M. Van Allen, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USAKevin Bi, Sabrina Y. Camp, Kevin Meli, Eddy Saad, Breanna M. Titchen, Chris Labaki, Erica M. Pimenta, Jihye Park, Erin Shannon, Jingxin Fu, Sherin Xirenayi, Eliezer M. Van Allen, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USASoki Kashima, Jeffrey J. Ishizuka, Toni K. Choueiri, David A. Braun, Center for Molecular and Cellular Oncology, Department of Medicine (Oncology), Yale School of Medicine, New Haven, CT, USASoki Kashima, Department of Urology, Akita University School of Medicine, Akita, JapanKevin Meli, Breanna M. Titchen, Division of Medical Sciences PhD Program in Biological and Biomedical Sciences, Harvard University, Cambridge, MA, USAChris Labaki, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAZiad Bakouny, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USASherin Xirenayi, Systems, Synthetic, and Quantitative Biology Graduate Program, Harvard University, Cambridge, MA, USALotus Lum, Jeffrey J. Ishizuka, Department of Immunobiology, Yale School of Medicine, New Haven, CT, USAJeffrey J. Ishizuka, Department of Pathology, Yale School of Medicine, New Haven, CT, USADavid A. Braun, Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.